ATA121486A - Verfahren zur herstellung neuer disubstituierter 1,4-piperazinylderivate - Google Patents

Verfahren zur herstellung neuer disubstituierter 1,4-piperazinylderivate

Info

Publication number
ATA121486A
ATA121486A AT0121486A AT121486A ATA121486A AT A121486 A ATA121486 A AT A121486A AT 0121486 A AT0121486 A AT 0121486A AT 121486 A AT121486 A AT 121486A AT A121486 A ATA121486 A AT A121486A
Authority
AT
Austria
Prior art keywords
producing new
piperazinyl derivatives
new disubstituted
disubstituted
piperazinyl
Prior art date
Application number
AT0121486A
Other languages
English (en)
Other versions
AT398572B (de
Inventor
James Stewart New
Joseph P Yevick
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of ATA121486A publication Critical patent/ATA121486A/de
Application granted granted Critical
Publication of AT398572B publication Critical patent/AT398572B/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT0121486A 1985-05-06 1986-05-06 Verfahren zur herstellung neuer disubstituierter 1,4-piperazinylderivate AT398572B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US73120185A 1985-05-06 1985-05-06

Publications (2)

Publication Number Publication Date
ATA121486A true ATA121486A (de) 1994-05-15
AT398572B AT398572B (de) 1994-12-27

Family

ID=24938510

Family Applications (1)

Application Number Title Priority Date Filing Date
AT0121486A AT398572B (de) 1985-05-06 1986-05-06 Verfahren zur herstellung neuer disubstituierter 1,4-piperazinylderivate

Country Status (25)

Country Link
JP (1) JPH0753728B2 (de)
KR (1) KR940000829B1 (de)
CN (1) CN1017901B (de)
AT (1) AT398572B (de)
AU (1) AU593244B2 (de)
BE (1) BE904724A (de)
CA (1) CA1278792C (de)
CH (1) CH672787A5 (de)
DE (1) DE3615180C2 (de)
DK (1) DK165745C (de)
EG (1) EG18206A (de)
ES (6) ES8801250A1 (de)
FI (1) FI85484C (de)
FR (1) FR2581385B1 (de)
GB (1) GB2174703B (de)
GR (1) GR861149B (de)
HU (1) HU195509B (de)
IE (1) IE59201B1 (de)
IT (1) IT1208607B (de)
LU (1) LU86421A1 (de)
MY (1) MY100777A (de)
NL (1) NL8601146A (de)
PT (1) PT82523B (de)
SE (1) SE465270B (de)
ZA (1) ZA862046B (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5801186A (en) * 1987-11-20 1998-09-01 Hoechst Marion Roussel, Inc. 3- 4-(1-substituted-4-piperazinyl)butyl!-4-thiazolidinone and related compounds
US4880930A (en) * 1987-11-30 1989-11-14 New James S Psychotropic acyclic amide derivatives
US4780466A (en) * 1988-03-17 1988-10-25 Hoechst-Roussel Pharmaceuticals, Inc. Arylpiperazinylalkoxy derivatives of cyclic imides
IE903410A1 (en) * 1989-10-09 1991-04-10 Novo Nordisk As Indole derivatives, their preparation and use
US5272148A (en) * 1992-09-09 1993-12-21 Hoechst-Roussel Pharmaceuticals Incorporated Heteroarenylpiperazines
FR2738822B1 (fr) * 1995-09-15 1997-10-31 Synthelabo Derives de 4-(omega-(4-(thieno(3,2-c)pyridin-4-yl)piperazin- 1-yl)alkyl)quinolein-2(1h)-one, leur preparation et leur application en therapeutique
SI0850235T1 (en) * 1995-09-15 2000-04-30 Sanofi-Synthelabo Quinolein-2(1h)-one derivatives as serotonin antagonists
FR2738824B1 (fr) * 1995-09-15 1997-10-31 Synthelabo Derives de 3-(omega(4-(thieno(3,2-c)pyridin-4-yl)piperazin-1 -yl)alkyl)-3,4-dihydroquinazolin-2(1h)-one,leur preparation et leur application en therapeutique
FR2738823B1 (fr) * 1995-09-15 1997-10-31 Synthelabo Derives de 3-(omega-(4-(thieno(3,2-c)pyridin-4-yl)piperazin- 1-yl)alkyl)-3,4-dihydroquinolein-2(1h)-one,leur preparation et leur application en therapeutique
FR2761071B1 (fr) * 1997-03-20 1999-12-03 Synthelabo Derives de quinolein-2(1h)-one et de dihydroquinolein-2(1h)- one, leur preparation et leur application en therapeutique
FR2797874B1 (fr) * 1999-08-27 2002-03-29 Adir Nouveaux derives de la pyridine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
US20040077605A1 (en) 2001-06-20 2004-04-22 Salvati Mark E. Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4367335A (en) * 1981-08-03 1983-01-04 Mead Johnson & Company Thiazolidinylalkylene piperazine derivatives
US4452799A (en) * 1981-12-23 1984-06-05 Mead Johnson & Company Benzisothiazole and benzisoxazole piperazine derivatives
US4361565A (en) * 1981-12-28 1982-11-30 Mead Johnson & Company 2-[4-[(4,4-Dialkyl-2,6-piperidinedion-1-yl)butyl]-1-piperazinyl]pyridines

Also Published As

Publication number Publication date
ES554659A0 (es) 1987-12-16
FI85484B (fi) 1992-01-15
GB2174703A (en) 1986-11-12
ZA862046B (en) 1986-11-26
GR861149B (en) 1986-09-09
AU593244B2 (en) 1990-02-08
AU5679586A (en) 1986-11-13
ES557855A0 (es) 1989-05-16
GB8610810D0 (en) 1986-06-11
KR860009008A (ko) 1986-12-19
MY100777A (en) 1991-02-14
PT82523B (pt) 1988-10-14
DK207186D0 (da) 1986-05-05
ES557839A0 (es) 1989-01-16
CN86103071A (zh) 1987-03-18
CH672787A5 (de) 1989-12-29
EG18206A (en) 1992-09-30
IE861193L (en) 1986-11-06
ES8802614A1 (es) 1988-09-01
JPS61268681A (ja) 1986-11-28
GB2174703B (en) 1988-10-26
IE59201B1 (en) 1994-01-26
FI85484C (fi) 1992-04-27
ES8900253A1 (es) 1989-05-16
LU86421A1 (fr) 1986-12-05
ES557809A0 (es) 1988-09-01
DK165745B (da) 1993-01-11
KR940000829B1 (ko) 1994-02-02
IT1208607B (it) 1989-07-10
DE3615180C2 (de) 1996-03-07
DK165745C (da) 1993-06-14
HUT43848A (en) 1987-12-28
IT8620313A0 (it) 1986-05-06
HU195509B (en) 1988-05-30
ES8900138A1 (es) 1989-01-16
SE8602061D0 (sv) 1986-05-05
PT82523A (en) 1986-06-01
SE8602061L (sv) 1986-11-07
NL8601146A (nl) 1986-12-01
AT398572B (de) 1994-12-27
FR2581385B1 (fr) 1991-10-04
ES9000005A1 (es) 1989-11-01
DE3615180A1 (de) 1986-11-06
CA1278792C (en) 1991-01-08
ES8802149A1 (es) 1988-04-01
ES557757A0 (es) 1988-04-01
CN1017901B (zh) 1992-08-19
DK207186A (da) 1986-11-07
ES8801250A1 (es) 1987-12-16
FI861820A7 (fi) 1986-11-07
FR2581385A1 (fr) 1986-11-07
FI861820A0 (fi) 1986-04-30
SE465270B (sv) 1991-08-19
BE904724A (fr) 1986-11-05
JPH0753728B2 (ja) 1995-06-07

Similar Documents

Publication Publication Date Title
ATA71183A (de) Verfahren zur herstellung neuer 3-keto-delta 4,9,19-norsteroid-derivate
ATA115486A (de) Verfahren zur herstellung neuer antibiotischer makrolite
DE3675687D1 (de) Verfahren zur herstellung von 2,2,6,6,-tetraalkyl-4-piperidylamine.
ATA364384A (de) Verfahren zur herstellung neuer 6-vinyl-furo(3,4-c)-pyridinderivate
DE3677272D1 (de) Verfahren zur herstellung von 2,2,6,6-tetraalkyl-4-piperidylaminen.
DE3667167D1 (de) Verfahren zur herstellung von 1,5-diazido-3-nitrazapentan.
DE3676215D1 (de) Verfahren zur herstellung von 2,3,4,5-tetrafluorbenzoesaeure.
DE3674055D1 (de) Verfahren zur herstellung von 1,3,5-triazintrionen.
ATA165685A (de) Verfahren zur herstellung neuer 1,3-oxazolidin-2- derivate
AT386208B (de) Verfahren zur herstellung neuer carbapenemzwischenverbindungen
AT387013B (de) Verfahren zur herstellung von poly-4-aminopyrrol -2-carboxamidoderivaten
ATA233086A (de) Verfahren zur herstellung neuer peptidantibiotika
DE3673049D1 (de) Verfahren zur herstellung von 1,3-dialkyl-2-imidazolidinon.
ATA337185A (de) Verfahren zur herstellung neuer flavolignanderivate
ATA124285A (de) Verfahren zur herstellung neuer iminothiazolidinderivate
ATA335685A (de) Verfahren zur herstellung neuer thienopyridinderivate
ATA310385A (de) Verfahren zur herstellung neuer 6-phenaethylaminoalkyl-7-hydroxy-furo-(3,4-c)pyridinderivate
DE3678125D1 (de) Verfahren zur herstellung von p-methoxybenzaldehyd.
ATA371584A (de) Verfahren zur herstellung neuer cephalosporanderivate
ATA305785A (de) Verfahren zur herstellung neuer 4h-dioxino-(4,5-c)-pyridinderivate
DE3683373D1 (de) Verfahren zur herstellung emulgierbarer polyethylen-paraffin-mischzubereitungen.
DE3671436D1 (de) Verfahren zur herstellung von 2,2,-dibrom-3-oxonitrilen.
ATA257386A (de) Verfahren zur herstellung neuer brenzcatechinderivate
AT385989B (de) Verfahren zur herstellung neuer derivate des 20,21-dinoreburnamenins
ATA323986A (de) Verfahren zur herstellung neuer 4-h-benzo(4,5)-cyclohepta(1,2-b)thiophenderivat

Legal Events

Date Code Title Description
ELA Expired due to lapse of time